Global Aging And Personalized Medicine Will Open Therapeutic Markets
AN
AnalystHighTarget
Not Invested
Consensus Narrative from 14 Analysts
Published
09 Jun 25
Updated
08 Aug 25
AnalystHighTarget's Fair Value
JP¥2,200.00
24.8% undervalued intrinsic discount08 Aug
JP¥1,654.50
1Y
-2.4%7D
3.1%